Trials / Enrolling By Invitation
Enrolling By InvitationNCT06802965
Shanghai Atrial Fibrillation Registry
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 400,000 (estimated)
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Using the Shanghai Municipal Health Commission database and Shanghai Centers for Disease Control and Prevention database, patients with AF in Shanghai are included to construct the Shanghai AF registry to investigate clinical characteristics, treatment, and prognosis.
Detailed description
1. To determine the most suitable risk stratification model for Chinese AF population regarding stroke and major cardiovascular events, i.e. CHA2DS2-VASc, CHA2DS2-VASc-60, or CHA2DS2-VA scores. 2. To compare the clinical prognosis of patients with AF receiving the combined procedure of catheter ablation and left atrial appendage closure (LAAC), single catheter ablation, and single LAAC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | catheter ablation, left atrial appendage closure | Compare the clinical prognosis of patients with AF underwent the combined procedure of catheter ablation and left atrial appendage closure (LAAC), single catheter ablation and single LAAC. |
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2028-01-01
- Completion
- 2030-01-01
- First posted
- 2025-01-31
- Last updated
- 2025-01-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06802965. Inclusion in this directory is not an endorsement.